Grants and Contributions:

Back to search
Title:
Operating Grant: TRANSCAN-3
Agreement Number:
179750
Agreement Value:
$537,048.00
Agreement Date:
Sep 1, 2024 - Aug 31, 2027
Description:
The specific objectives of this funding opportunity are: • To improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics. • To stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.
Organization:
Canadian Institutes of Health Research
Expected Results:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Location:
Vancouver, British Columbia, CA V6T 1Z1
Reference Number:
236-2024-2025-Q2-00626
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:

Amendment 1: Agreement Value in CAD.

Amendment Date
Sep 30, 2025
Recipient's Legal Name:
Weng, Andrew P
Research Organization:
University of British Columbia
Program:
Research in Priority Areas
Program Purpose:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Amendments:
See Amendments